Andrew B Nixon

Andrew B Nixon

UNVERIFIED PROFILE

Are you Andrew B Nixon?   Register this Author

Register author
Andrew B Nixon

Andrew B Nixon

Publications by authors named "Andrew B Nixon"

Are you Andrew B Nixon?   Register this Author

57Publications

1038Reads

42Profile Views

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.

Prostate 2019 Nov 9;79(15):1752-1761. Epub 2019 Sep 9.

Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23899DOI Listing
November 2019

Phase II study of Dovitinib in recurrent glioblastoma.

J Neurooncol 2019 Sep 11;144(2):359-368. Epub 2019 Jul 11.

Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, S73, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03236-6DOI Listing
September 2019

EGFR-Dependent IL8 Production by Airway Epithelial Cells After Exposure to the Food Flavoring Chemical 2,3-Butanedione.

Toxicol Sci 2019 Jun;169(2):534-542

Division of Pulmonary and Critical Care medicine, Duke University Medical Center, Durham, NC 27710.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/toxsci/kfz066DOI Listing
June 2019

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.

Cancer Chemother Pharmacol 2019 Jun 20;83(6):1025-1035. Epub 2019 Mar 20.

Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3505, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03805-6DOI Listing
June 2019

Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.

Mol Cancer Ther 2018 10 11;17(10):2248-2256. Epub 2018 Jul 11.

Department of Medicine, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0916DOI Listing
October 2018

Cabozantinib in ovarian clear cell cancers: UnMET expectations.

Gynecol Oncol 2018 07;150(1):1-2

Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.06.006DOI Listing
July 2018

Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.

Radiology 2017 10 8;285(1):311-318. Epub 2017 Aug 8.

From the Department of Radiology, Division of Vascular & Interventional Radiology (J.R., D.M., R.T.G., G.J., W.C., P.V.S., W.P.R., D.R.S., C.Y.K.), and Department of Medicine (A.B.N., M.D.S., J.C.B., H.I.H.), Duke University Medical Center, Box 3808 Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017162555DOI Listing
October 2017

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.

Neuro Oncol 2017 Sep;19(9):1217-1227

Department of Neurosurgery, Duke University, Durham, North Carolina; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina; Brain Imaging and Analysis Center, Duke University, Durham, North Carolina; Department of Radiology, Duke University, Durham, North Carolina; Department of Radiology, Stanford University, Palo Alto, California; Department of Medicine, Duke University, Durham, North Carolina; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; Department of Pathology, Duke University, Durham, North Carolina; Division of Haematology/Oncology, the Arthur and Sonia Labatt Brain Tumour Research Centre, Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Division of Neurosurgery, the Arthur and Sonia Labatt Brain Tumour Research Centre, Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570262PMC
September 2017

Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies.

Urol Oncol 2016 11 4;34(11):510-518. Epub 2016 Aug 4.

Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.06.020DOI Listing
November 2016

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).

EBioMedicine 2015 Nov 8;2(11):1814-20. Epub 2015 Sep 8.

Department of Biostatistics and Bioinformatics, and Alliance Statistics and Data Center, Duke University, Durham, NC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740313PMC
November 2015

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2015 Feb 20;75(2):343-52. Epub 2014 Dec 20.

Duke Cancer Institute, Duke University Medical Center, Box 3052, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2647-xDOI Listing
February 2015

A leave-one-out cross-validation SAS macro for the identification of markers associated with survival.

Comput Biol Med 2015 Feb 9;57:123-9. Epub 2014 Dec 9.

Department of Biostatistics and Bioinformatics & Duke Cancer Biostatistics, Duke University School of Medicine, Durham, NC, United States; School of Public Health, Li Ka Shing Faculty of Medicine, Pok Fu Lam, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2014.11.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306627PMC
February 2015

The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer.

Gynecol Oncol 2014 Nov 30;135(2):349-58. Epub 2014 Aug 30.

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.033DOI Listing
November 2014

Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.

Invest New Drugs 2014 Oct 5;32(5):851-9. Epub 2014 Jul 5.

Department of Medicine, Duke University Medical Center, Box 2631, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0129-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169868PMC
October 2014

A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma.

Clin Genitourin Cancer 2014 Aug 14;12(4):241-50. Epub 2013 Nov 14.

Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623321PMC
August 2014

Role of TGF-β receptor III localization in polarity and breast cancer progression.

Mol Biol Cell 2014 Aug 28;25(15):2291-304. Epub 2014 May 28.

Department of Medicine, Duke University Medical Center, Durham, NC 27710

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.E14-03-0825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116303PMC
August 2014

Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.

Mol Biol Cell 2014 Aug 25;25(16):2320-32. Epub 2014 Jun 25.

Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27708Department of Medicine, Duke University, Durham, NC 27708

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.E13-09-0524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142606PMC
August 2014

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data.

Cancer Inform 2014 28;13(Suppl 4):1-9. Epub 2014 Jul 28.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. ; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CIN.S13634DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125381PMC
August 2014

The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.

Neoplasia 2014 Jun;16(6):489-500

Department of Medicine, Duke University Medical Center, Durham, NC; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2014.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198744PMC
June 2014

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).

Clin Cancer Res 2013 Dec 4;19(24):6957-66. Epub 2013 Oct 4.

Authors' Affiliations: Division of Medical Oncology; Alliance Statistics and Data Center, Duke University Medical Center; Durham, North Carolina; Section of Hematology/Oncology, University of Chicago Cancer Research Center; Chicago, Illinois; Department of Surgery, Brigham and Women's Hospital & Harvard Medical School; Boston, Massachusetts; Department of Internal Medicine, Ohio State University; Columbus, Ohio; and Division of Medical Oncology, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-0926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219241PMC
December 2013

Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer.

Anticancer Drugs 2013 Mar;24(3):237-50

Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e32835d29fdDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828660PMC
March 2013

Effect of pazopanib on tumor microenvironment and liposome delivery.

Mol Cancer Ther 2010 Jun 1;9(6):1798-808. Epub 2010 Jun 1.

Duke University School of Medicine, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909540PMC
June 2010

Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression.

Hypertension 2009 Sep 3;54(3):652-8. Epub 2009 Aug 3.

Division of Nephrology, Department of Medicine, Duke University Medical Center, 106 Research Drive, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.129973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746822PMC
September 2009

A role for G(z) in pancreatic islet beta-cell biology.

J Biol Chem 2005 Sep 6;280(36):31708-13. Epub 2005 Jul 6.

Department of Pharmacology and Cancer Biology, Duke University, Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M506700200DOI Listing
September 2005

Analysis of the regulation of microtubule dynamics by interaction of RGSZ1 (RGS20) with the neuronal stathmin, SCG10.

Methods Enzymol 2004 ;390:53-64

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S007668790490004
Publisher Site
http://dx.doi.org/10.1016/S0076-6879(04)90004-3DOI Listing
February 2005

Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases.

Biochim Biophys Acta 2002 Oct;1592(2):175-84

Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-4889(02)00314-2DOI Listing
October 2002

The interaction of RGSZ1 with SCG10 attenuates the ability of SCG10 to promote microtubule disassembly.

J Biol Chem 2002 May 6;277(20):18127-33. Epub 2002 Mar 6.

Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710-3813, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/content/early/2002/03/06/jbc.M201065200.f
Web Search
http://www.jbc.org/cgi/doi/10.1074/jbc.M201065200
Publisher Site
http://dx.doi.org/10.1074/jbc.M201065200DOI Listing
May 2002